These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. Focus on the Use of Resveratrol in Bladder Cancer. Zucchi A; Claps F; Pastore AL; Perotti A; Biagini A; Sallicandro L; Gentile R; Caglioti C; Palazzetti F; Fioretti B Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901993 [TBL] [Abstract][Full Text] [Related]
104. Mechanism of Resveratrol-Induced Programmed Cell Death and New Drug Discovery against Cancer: A Review. Jang JY; Im E; Kim ND Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430164 [TBL] [Abstract][Full Text] [Related]
105. Potential Therapeutic Targets of Resveratrol, a Plant Polyphenol, and Its Role in the Therapy of Various Types of Cancer. Almatroodi SA; A Alsahli M; S M Aljohani A; Alhumaydhi FA; Babiker AY; Khan AA; Rahmani AH Molecules; 2022 Apr; 27(9):. PubMed ID: 35566016 [TBL] [Abstract][Full Text] [Related]
106. The Role of Epigenetic Modifications in Human Cancers and the Use of Natural Compounds as Epidrugs: Mechanistic Pathways and Pharmacodynamic Actions. Bouyahya A; Mechchate H; Oumeslakht L; Zeouk I; Aboulaghras S; Balahbib A; Zengin G; Kamal MA; Gallo M; Montesano D; El Omari N Biomolecules; 2022 Feb; 12(3):. PubMed ID: 35327559 [TBL] [Abstract][Full Text] [Related]
107. Sinomenine Inhibits the Progression of Bladder Cancer Cells by Downregulating LncRNA-HEIH Expression. Xu H; Dong J; Hou J; Gao R Evid Based Complement Alternat Med; 2021; 2021():4699529. PubMed ID: 34760016 [TBL] [Abstract][Full Text] [Related]
108. Resveratrol effects in bladder cancer: A mini review. Almeida TC; Silva GND Genet Mol Biol; 2021; 44(1):e20200371. PubMed ID: 33749701 [TBL] [Abstract][Full Text] [Related]
109. Resveratrol, curcumin, paclitaxel and miRNAs mediated regulation of PI3K/Akt/mTOR pathway: go four better to treat bladder cancer. Khan K; Quispe C; Javed Z; Iqbal MJ; Sadia H; Raza S; Irshad A; Salehi B; Reiner Ž; Sharifi-Rad J Cancer Cell Int; 2020 Nov; 20(1):560. PubMed ID: 33292283 [TBL] [Abstract][Full Text] [Related]
110. Broad-Spectrum Preclinical Antitumor Activity of Chrysin: Current Trends and Future Perspectives. Moghadam ER; Ang HL; Asnaf SE; Zabolian A; Saleki H; Yavari M; Esmaeili H; Zarrabi A; Ashrafizadeh M; Kumar AP Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32992587 [TBL] [Abstract][Full Text] [Related]
111. Protective effect of resveratrol on estrogen deficiency-induced osteoporosis though attenuating NADPH oxidase 4/nuclear factor kappa B pathway by increasing miR-92b-3p expression. Zhang Y; Liu MW; He Y; Deng N; Chen Y; Huang J; Xie W Int J Immunopathol Pharmacol; 2020; 34():2058738420941762. PubMed ID: 32674689 [TBL] [Abstract][Full Text] [Related]
112. Resveratrol induces apoptosis of benign prostatic hyperplasia epithelial cell line (BPH-1) through p38 MAPK-FOXO3a pathway. Li C; Hu WL; Lu MX; Xiao GF BMC Complement Altern Med; 2019 Aug; 19(1):233. PubMed ID: 31464618 [TBL] [Abstract][Full Text] [Related]
113. Inhibition of urinary bladder cancer cell proliferation by silibinin. Barros TMB; Lima APB; Almeida TC; da Silva GN Environ Mol Mutagen; 2020 Apr; 61(4):445-455. PubMed ID: 32078183 [TBL] [Abstract][Full Text] [Related]
114. Cytotoxic and toxicogenomic effects of silibinin in bladder cancer cells with different TP53 status. DE Oliveira DT; Savio AL; Marcondes JP; Barros TM; Barbosa LC; Salvadori DM; DA Silva GN J Biosci; 2017 Mar; 42(1):91-101. PubMed ID: 28229968 [TBL] [Abstract][Full Text] [Related]
115. Cell cycle kinetics, apoptosis rates, DNA damage and TP53 gene expression in bladder cancer cells treated with allyl isothiocyanate (mustard essential oil). Savio AL; da Silva GN; de Camargo EA; Salvadori DM Mutat Res; 2014 Apr; 762():40-6. PubMed ID: 24625788 [TBL] [Abstract][Full Text] [Related]
116. Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasis. McCubrey JA; Lertpiriyapong K; Fitzgerald TL; Martelli AM; Cocco L; Rakus D; Gizak A; Libra M; Cervello M; Montalto G; Yang LV; Abrams SL; Steelman LS Adv Biol Regul; 2017 Jan; 63():32-48. PubMed ID: 27776972 [TBL] [Abstract][Full Text] [Related]
117. Antiproliferative and toxicogenomic effects of resveratrol in bladder cancer cells with different TP53 status. Almeida TC; Guerra CCC; De Assis BLG; de Oliveira Aguiar Soares RD; Garcia CCM; Lima AA; da Silva GN Environ Mol Mutagen; 2019 Oct; 60(8):740-751. PubMed ID: 31095781 [TBL] [Abstract][Full Text] [Related]